PubRank

Paola Parrella

Author PubWeight™ 31.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res 2002 7.09
2 Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin Cancer Res 2002 1.97
3 Cetuximab plus FOLFOX-4 in untreated patients with advanced colorectal cancer: a Gruppo Oncologico dell'Italia Meridionale Multicenter phase II study. Oncology 2011 1.48
4 Mouse mammary tumor-like env gene as a molecular marker for breast cancer? Int J Cancer 2002 1.47
5 Changes in CpG islands promoter methylation patterns during ductal breast carcinoma progression. Cancer Epidemiol Biomarkers Prev 2009 1.43
6 Lack of BRAF mutation in primary uveal melanoma. Invest Ophthalmol Vis Sci 2003 1.26
7 Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome. Epigenetics 2011 1.20
8 Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer. Epigenetics 2011 1.12
9 High RAD51 mRNA expression characterize estrogen receptor-positive/progesteron receptor-negative breast cancer and is associated with patient's outcome. Int J Cancer 2010 1.01
10 Electroporation of skeletal muscle induces danger signal release and antigen-presenting cell recruitment independently of DNA vaccine administration. Expert Opin Biol Ther 2008 1.00
11 The fragile X protein binds mRNAs involved in cancer progression and modulates metastasis formation. EMBO Mol Med 2013 0.99
12 Aberrant Keap1 methylation in breast cancer and association with clinicopathological features. Epigenetics 2012 0.97
13 Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma. Cell Cycle 2013 0.96
14 Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Lett 2007 0.93
15 Molecular analysis of the HuD gene in neuroendocrine lung cancers. Lung Cancer 2010 0.84
16 Differential modulation of Ku70/80 DNA-binding activity in a patient with multiple basal cell carcinomas. J Invest Dermatol 2003 0.83
17 Aberrant promoter methylation of beta-1,4 galactosyltransferase 1 as potential cancer-specific biomarker of colorectal tumors. Genes Chromosomes Cancer 2012 0.83
18 Small deletion at the 7q21.2 locus in a CCM family detected by real-time quantitative PCR. J Biomed Biotechnol 2010 0.82
19 DNA end binding activity and Ku70/80 heterodimer expression in human colorectal tumor. World J Gastroenterol 2005 0.81
20 Comparison between real-time quantitative PCR detection of HER2 mRNA copy number in peripheral blood and ELISA of serum HER2 protein for determining HER2 status in breast cancer patients. Cell Oncol 2009 0.81
21 Molecular dissection of the VHL gene in solitary capillary hemangioblastoma of the central nervous system. J Neuropathol Exp Neurol 2014 0.79
22 Feasibilty of in utero DNA vaccination following naked gene transfer into pig fetal muscle: transgene expression, immunity and safety. Vaccine 2005 0.79
23 Gene expression of somatostatin receptor subtypes SSTR2a, SSTR3 and SSTR5 in peripheral blood of neuroendocrine lung cancer affected patients. Cell Oncol (Dordr) 2011 0.78
24 Comparison of circadian characteristics for cytotoxic lymphocyte subsets in non-small cell lung cancer patients versus controls. Clin Exp Med 2011 0.78
25 Development of real-time quantitative reverse transcription-PCR for Her2 detection in peripheral blood from patients with breast cancer. Clin Chim Acta 2007 0.77
26 VHL gene alterations in Italian patients with isolated renal cell carcinomas. Int J Biol Markers 2013 0.75
27 Aberrant genes promoter methylation in neural crest-derived tumors. Int J Biol Markers 2012 0.75